The state of Pennsylvania currently has 555 active clinical trials seeking participants for Cancer research studies. These trials are conducted in various cities, including Philadelphia, Pittsburgh, Hershey and Allentown.
CyberKnife Dose Escalation Prostate Cancer Trial
Recruiting
Stereotactic body radiation therapy (SBRT) has been employed in the treatment of prostate cancer. Multiple single institution experiences suggest high biochemical control rates with acceptable toxicity in low risk prostate cancer but efficacy data in unfavorable type prostate cancer is less convincing. CyberKnife-SBRT (CK-SBRT) can be used to escalate radiation dose delivery to the prostate while sparing normal tissue.
Gender:
Male
Ages:
18 years and above
Trial Updated:
04/19/2021
Locations: Crozer Keystone Health System/Philadelphia CyberKnife Center, Havertown, Pennsylvania
Conditions: Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm
Photodynamic Therapy (PDT) Oncology Registry
Recruiting
The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/23/2018
Locations: Main Line Health, Lankenau Medical Center, Wynnewood, Pennsylvania
Conditions: Lung Cancer, Esophageal
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Recruiting
This research study is looking at tumor tissue samples from patients who have undergone surgery for advanced stage III or stage IV ovarian epithelial cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn how tumor infiltrating T cells can predict how patients will respond to treatment.
Gender:
Female
Ages:
All
Trial Updated:
05/02/2017
Locations: Gynecologic Oncology Group, Philadelphia, Pennsylvania
Conditions: Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer, Stage IV Ovarian Cancer